Per Guldberg

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Smoking Cessation

Muscle Invasive Bladder Cancer

Mesenchymal Stem Cells

Top Venues

Molecular cancer

Nature communications

Cancer research communications

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Zita Gál, Stavroula Boukoura, Kezia Catharina Oxe, Sara Badawi, Blanca Nieto, Lea Milling Korsholm, Sille Blangstrup Geisler, Ekaterina Dulina, Anna Vestergaard Rasmussen, Christina Dahl, Wei Lv, Huixin Xu, Xiaoguang Pan, Stefanos Arampatzis, Danai-Eleni Stratou, Panagiotis Galanos, Lin Lin, Per Guldberg, Jiri Bartek, Yonglun Luo, Dorthe Helena Larsen
Hyper-recombination in ribosomal DNA is driven by long-range resection-independent RAD51 accumulation. Nature communications 15 (1) (2024)
Hege Marie Vedeld, Heidi Pharo, Anne Klara Sørbø, Sara Brandt-Winge, May-Britt Five, Marine Jeanmougin, Per Guldberg, Rolf Wahlqvist, Guro Elisabeth Lind
Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer. Molecular oncology (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Odd L Gammelgaard, Mikkel G Terp, Alexei F Kirkin, Simone Johansen, Sofie Traynor, Henriette Vever, Per Guldberg, Annette Raskov Kodahl, Morten Frier Gjerstorff, Henrik Jørn Ditzel
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Molecular cancer 23 (1) (2024)
Christina Dahl, Ulla Arthur Hvidtfeldt, Anne Tjønneland, Per Guldberg, Ole Raaschou-Nielsen
Blood Leukocyte AHRR Methylation and Risk of Non-smoking-associated Cancer: A Case-cohort Study of Non-Hodgkin Lymphoma. Cancer research communications 3 (9) (2023)
Luca Di Leo, Valérie Bodemeyer, Francesca M Bosisio, Giuseppina Claps, Marco Carretta, Salvatore Rizza, Fiorella Faienza, Alex Frias, Shawez Khan, Matteo Bordi, Maria P Pacheco, Julie S Di Martino, Jose J Bravo-Cordero, Colin J Daniel, Rosalie C Sears, Marco Donia, Daniel H Madsen, Per Guldberg, Giuseppe Filomeni, Thomas Sauter, Caroline Robert, Daniela De Zio, Francesco Cecconi
Loss of Ambra1 promotes melanoma growth and invasion. Nature communications 12 (1) (2021)
Alexei F Kirkin, Karine N Dzhandzhugazyan, Per Guldberg, Johnny Jon Fang, Rikke Sick Andersen, Christina Dahl, Jann Mortensen, Tim Lundby, Aase Wagner, Ian Law, Helle Broholm, Line Madsen, Christer Lundell-Ek, Morten Frier Gjerstorff, Henrik Jørn Ditzel, Martin R Jensen, Walter Fischer
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells. Nature communications 9 (1) (2018)